Pneumocystis jirovecii pneumonia (PJP) is increasingly seen in association with the use of
new and potent immunosuppressive therapies in populations not infected with human …

Clin Microbiol Infect 2012; 18: 598–603 Abstract Pneumocystis jirovecii pneumonia (PCP) is
a leading cause of morbidity and mortality in immunocompromised patients. Despite the …

Introduction. Pneumocystis jirovecii is an opportunistic fungus that affects mainly people
living with HIV (CD4 cell count lower than 200 cells/ml) and other immunosuppressed …

A total of 327 clinical specimens, including both invasive and noninvasive samples,
obtained from 275 patients with various types of underlying immunocompromised conditions …

It remains a huge challenge for clinicians to diagnose Pneumocystis jirovecii pneumonia
(PJP) by a conventional method, which leads to delay in diagnosing PJP, accounting for …

Pneumocystis jirovecii can cause fatal Pneumocystis pneumonia (PcP). Many children have
been exposed to the fungus and are colonized in early age, while some individuals at high …

Pneumocystis pneumonia (PCP), a common and serious opportunistic infection in
immunocompromised patients, is caused by Pneumocystis jirovecii (formerly known as …

Background: Pneumocystis pneumonia (PCP) is conventionally diagnosed by identifying
Pneumocystis jirovecii in lower respiratory tract samples using cytochemical stains …

Background Pneumocystis pneumonia (PCP) is a fatal infectious disease caused by
Pneumocystis jirovecii (PJP). The major factor relevant to morbidity and mortality seems to …

Pneumocystis spp. was discovered in 1909 and was classified as a fungus in 1988. The
species that infects humans is called P. jirovecii and important characteristics of its genome …